On Jun. 16, 2020, lower-income countries across the world have access life-saving pneumococcal conjugate vaccines, which protect against the leading cause of pneumonia, for US$ 2 per dose, thanks to a supply agreement between UNICEF, Gaviﾒs procurement partner, and the Serum Institute of India (SII). The new price represents a 43 per cent reduction from the Gavi price of US$3.50 at the start of the Advance Market Commitment.